MedTrace Logo

CE-IOUS Impact on Surgical Strategy of Liver Tumours and Liver Metastases

NCT05261113 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-03-17

No results posted yet for this study

Summary

Contrast-enhanced intraoperative ultrasound (CE-IOUS) plays an increasingly important role in the surgical therapy planning of primary liver lesions as well as liver metastases.

The present study was designed to evaluate the significance of CE-IOUS by specificity and sensitivity and particularly the impact it exerts on the surgical strategy.

A secondary aim was assessing the outcome relevance of surgeries influenced by CE-IOUS.

Conditions

  • Liver Neoplasms
  • Liver/Hepatobiliary Cancer
  • Colorectal Cancer Metastatic
  • Metastases
  • Surgery
  • Ultrasound

Interventions

PROCEDURE

CE-IOUS

Use of contrast-enhanced intraoperative ultrasound during liver surgery

Sponsors & Collaborators

  • University of Regensburg

    lead OTHER

Principal Investigators

  • Hans J Schlitt, MD Prof. · Head of Department

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05261113 on ClinicalTrials.gov